Francesco Curra
Directeur Technique/Scientifique/R&D chez Cerevast Medical, Inc.
Profil
Francesco Curra founded Novuson Surgical, Inc. in 2014, where he worked as Director & Chief Technology Officer from 2014 to 2017.
Dr. Curra also currently works at Cerevast Medical, Inc., as Chief Technology Officer from 2018 and Longevity Biomedical, Inc., as Chief Technology Officer.
Dr. Curra received his doctorate degree from the University of Washington and undergraduate degree from Syracuse University.
Postes actifs de Francesco Curra
| Sociétés | Poste | Début |
|---|---|---|
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Directeur Technique/Scientifique/R&D | 01/04/2018 |
Anciens postes connus de Francesco Curra
| Sociétés | Poste | Fin |
|---|---|---|
Novuson Surgical, Inc.
 Novuson Surgical, Inc. Medical SpecialtiesHealth Technology Novuson Surgical, Inc. manufactures surgical devices. It develops a hemostatic platform technology for ablating tissue, isolating tumors, and providing hemostatic control prior to and during surgery. The company was founded by Stuart B. Mitchell in February 2014 and is headquartered in Bothell, WA. | Fondateur | 01/08/2017 |
Formation de Francesco Curra
| Syracuse University | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cerevast Medical, Inc.
Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
Novuson Surgical, Inc.
Novuson Surgical, Inc. Medical SpecialtiesHealth Technology Novuson Surgical, Inc. manufactures surgical devices. It develops a hemostatic platform technology for ablating tissue, isolating tumors, and providing hemostatic control prior to and during surgery. The company was founded by Stuart B. Mitchell in February 2014 and is headquartered in Bothell, WA. | Health Technology |
